Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.
about
Differences between men with screening-detected versus clinically diagnosed prostate cancers in the USARacial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adultsDetermination of county-level prostate carcinoma incidence and detection rates with Medicare claims data.Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1)Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gapMultilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida.Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data.Racial differences in PSA screening interval and stage at diagnosis.Social and ethical implications of genomics, race, ethnicity, and health inequities.Understanding regional variation in Medicare expenditures for initial episodes of prostate cancer care.Are HIV-infected men vulnerable to prostate cancer treatment disparities?An economic overview of prostate carcinoma.Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes studyLocoregional prostate cancer treatment pattern variation in independent cancer centers: policy effect, patient preference, or physician incentive?Understanding the psychosocial issues of African American couples surviving prostate cancerRacial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.A new approach to understanding racial disparities in prostate cancer treatment.Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer.Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis.Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.Access to information sources and treatment considerations among men with local stage prostate cancer.Life-Threatening Disparities: The Treatment of Black and White Cancer Patients.Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use.Trends and patterns of utilization in post-treatment surveillance imaging among patients treated for hepatocellular carcinoma.Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.Geographical Factors Associated With Health Disparities in Prostate Cancer.Adherence by African American men to prostate cancer education and early detection.Survival and treatment for colorectal cancer Medicare patients in two group/staff health maintenance organizations and the fee-for-service setting.Prostate carcinoma trends in three counties in Sweden 1987-1996: results from a population-based national cancer register. South-East Region Prostate Cancer Group.Race and outcomes: is this the end of the beginning for minority health research?Improvement of racial disparities with respect to the utilization of minimally invasive radical prostatectomy in the United States.Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina.Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study Group.Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system.Clinical characteristics of African-American men with hereditary prostate cancer: the AAHPC Study.Comparison of the epidemiologic features and patterns of initial care for prostate cancer between public and private institutions: a survey by the Brazilian Society of Urology.The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer.Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.
P2860
Q24805151-52A6A583-5042-4978-B606-CF8C5DFCD41CQ30418988-2061B00C-2AD9-4696-81EE-E129913BEE07Q30655766-EB1C9BE2-1CF0-4601-BF32-1F344F6A6E1CQ31127274-971E20F9-C2D9-4C0E-8BE5-8B92BF2BB1A9Q33559123-18BE8A6E-DBDB-483E-B334-189FBD5C8C7FQ33606053-1B7C0928-DE54-4ECD-A21A-131895E9E87EQ33693397-05866BAD-2895-4A51-89B6-0C4B7EC377ACQ33718192-BED32C75-85FA-4789-ACCD-12C47E41E2E7Q33905826-DE6CF21E-A2F8-4D12-A72A-C9CE93D977E7Q33942048-3E406BEA-ACAE-4D7B-BECE-613953B46468Q34031640-CD8CE5F4-C880-4887-9B34-AD336DDC153BQ34288005-EFDC0CE6-42F8-450F-BF4C-156BDA680A96Q34468887-C7FDC83C-BB4B-4A0A-B8FF-FA03236B63DBQ34742544-57AE8F89-C0D6-409E-8562-963C99A15253Q35459197-07C65E99-4F8A-49FC-A051-B488FD91673DQ35835678-9F5D3533-9B9D-49E5-9D8D-8F1CFFB7897DQ36421159-EEB34459-4F94-43E0-A2C9-0D9C684F5663Q36971869-407D0CEA-548B-41A6-B66D-3550DD513099Q37149323-8075AF4F-927B-452C-AEE4-4AEBE53D5E37Q37152796-5ECD89F9-0E6B-4F8D-B736-9863D6086735Q37246641-CD85FF6C-D898-4C98-93D1-F14BEC369C62Q37356222-617E7F8C-434E-4192-9C15-6D3E4438C227Q37361918-5752CC97-EFDF-4C7D-B0C8-FBB9F4836752Q37427019-AAB5ED7F-8426-4434-AFAF-52B8FA9C4E3BQ37691453-A5CEA656-6528-4542-857A-A390C236DD6FQ38491112-9C4825CD-2818-4C4A-AD67-53B1A5623C04Q40476413-0BCEE7BD-6B44-4703-959D-1BF2B4929EA1Q40807289-795F585A-74EE-48C8-9F23-50C7C281D937Q41673495-8366172E-ABE6-4576-9F18-6D51FC92ECF6Q44184008-B4B75D63-79FA-4795-9065-7B79A5FF28AEQ46266975-05487130-9B8C-42C2-8266-55B3A453CEA2Q46526279-71B94820-4BF0-4D96-892C-2A0DCAB39FB9Q46532776-31890C52-ADDA-4871-BFF7-EF32177AFCB3Q46708843-3CCDB7E9-6086-48B6-A32F-BDFC0ABAF241Q46797435-44DDB7E5-B0E6-4362-9926-AC863CE836CFQ47399749-786732A3-AB95-4504-BA3C-3509C0AD005BQ47813833-48ADA37D-2C10-4F55-B60D-E02084ABE6CCQ50660250-0F31D861-CE83-49B7-8CB4-C9156192B437Q52898226-92E18BA8-FCEC-40AE-A101-34FA86F065DEQ52913260-83D7152F-8118-493A-8CE7-F0DED7CBA77E
P2860
Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Geographic, age, and racial va ...... nal carcinoma of the prostate.
@en
Geographic, age, and racial va ...... nal carcinoma of the prostate.
@nl
type
label
Geographic, age, and racial va ...... nal carcinoma of the prostate.
@en
Geographic, age, and racial va ...... nal carcinoma of the prostate.
@nl
prefLabel
Geographic, age, and racial va ...... nal carcinoma of the prostate.
@en
Geographic, age, and racial va ...... nal carcinoma of the prostate.
@nl
P2093
P356
P1476
Geographic, age, and racial va ...... nal carcinoma of the prostate.
@en
P2093
P304
P356
10.1200/JCO.1995.13.1.93
P407
P577
1995-01-01T00:00:00Z